Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of fluorinated drug compounds where the trifluoromethyl group enhances metabolic stability and bioavailability. Its bromo functionality allows for further cross-coupling reactions, making it valuable in building complex organic molecules, especially in medicinal chemistry and agrochemical research. Commonly employed in Suzuki and other palladium-catalyzed reactions to form carbon-carbon bonds. Also utilized in the preparation of chiral catalysts and functional materials due to its reactive and structurally distinct features.